Moneycontrol PRO

Black Friday Sale

Black Friday Sale

you are here: HomeNewsBusinessStocksSee more upside for Biocon post Syngene listing: Phillipcap

SHOW NAMES

Trending Topics

business

See more upside for Biocon post Syngene listing: Phillipcap

Biocon plans to list its research arm Syngene and on Wednesday filed prospectus with the market regulator Sebi. It aims to raise around Rs 600 crore.

first published: Apr 23, 2015 09:20 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell
Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347